Clinical Trials Logo

Mental Retardation clinical trials

View clinical trials related to Mental Retardation.

Filter by:

NCT ID: NCT02245724 Withdrawn - Mental Retardation Clinical Trials

Stem Cell Therapy in Mental Retardation

Start date: September 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study was to analyze the benefit of autologous mononuclear cell therapy in mental retardation.

NCT ID: NCT02214745 Not yet recruiting - Cerebral Palsy Clinical Trials

Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community

Start date: October 2014
Phase: N/A
Study type: Observational

To evaluate the demographic characteristics of patients suffering from mental retardation or cerebral palsy in the Israeli Arab community. Specific questionnaires will be developed and will be distributed amongst this population in order to identify these characteristics.

NCT ID: NCT01908400 Recruiting - Mental Retardation Clinical Trials

Safety and Efficacy of BMMNCin Patients With Mental Retardation

Start date: September 2014
Phase: Phase 1/Phase 2
Study type: Interventional

Mental retardation is a condition diagnosed before age 18 that includes below-average general intellectual function, and a lack of the skills necessary for daily living. Mental retardation affects about 1 - 3% of the population. There are many causes of mental retardation, but find a specific reason in only 25% of cases.Bone marrow derived stem cells are used in this condition to prove its safety and efficacy .

NCT ID: NCT01517048 Completed - Obesity Clinical Trials

Brain-Derived Neurotrophic Factor in Obesity and Brain Function

Start date: January 9, 2012
Phase:
Study type: Observational

Background: - Prader-Willi syndrome (PWS) and MC4R genetic mutations are two conditions that can cause problems with appetite regulation. People with PWS often have behavior and thinking problems. People with MC4R mutations may have problems with attention. These problems may be related to Brain-Derived Neurotrophic Factor (BDNF), a protein that is important for brain development. Researchers want to study people with PWS and MC4R mutations to see how BDNF is involved in these conditions. Specifically, body weight and brain function will be studied, and compared with healthy volunteers. Objectives: - To study how BDNF affects body weight and brain function in people with PWS and MC4R mutations. Eligibility: - Individuals of any age who have Prader-Willi syndrome or MC4R genetic mutations. - Healthy volunteers of any age to act as control participants. Design: - Participants will be screened with a medical history and physical exam. Height, weight, and waist/hip circumferences will be measured. Blood samples will be taken for genetic and other tests. - Participants will fill out questionnaires about eating habits, pain perception, and sleep behavior. - Participants will keep a 3-day food diary to record all food and drinks eaten. - Tests and questionnaires will be given to study thinking, speech, movement, behavior, and mood. Some tests will be done on a computer; other tests will be on paper. Tests may also involve performing tasks with blocks and other objects. - Participants may have other tests as directed. These will include hot and cold sensitivity tests, imaging studies like x-rays, and measurements of body fat and water content. - Treatment will not be provided as part of this study.

NCT ID: NCT01456910 Completed - Muscle Weakness Clinical Trials

Resistance Training Program, Labor Inclusion, Intellectual Disability

Start date: June 2009
Phase: N/A
Study type: Interventional

Resistance exercise (RE) has been proposed as a possible strategy for prevention and rehabilitation of diseases. The increase in both muscle strength and the ability to perform tasks of day-to-day work environment and are well-characterized benefits of this type of training. The literature has been investigating the effectiveness of the RE for humans, yet few studies have been conducted with intellectual disabilities (ID). It is known that a sedentary lifestyle contributes to the development of cardiovascular disease, type 2 diabetes, hypertension, arthritis, and stress, depression, difficulty in socializing, stigma and discrimination. In particular, the ID is less active and is more likely to develop secondary diseases.

NCT ID: NCT01430845 Completed - Cerebral Palsy Clinical Trials

Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay

Start date: September 1, 2011
Phase:
Study type: Observational

The purpose of this study is to find the relationship between the stage and quality of developmental delay during infancy and toddler age, and the final diagnosis that the child gets a few years later (MR, type of PDD, CP or comorbidity of a few disorders).

NCT ID: NCT01291238 Completed - Weight Loss Clinical Trials

School Intervention With Daily Physical Activity and Healthy Food for Students With an Intellectual Disability.

Start date: March 2004
Phase: N/A
Study type: Interventional

A whole of school intervention with daily physical activity and healthy food for students with intellectual disabilities. The aim is to provide plenty of concrete examples of healthy life style choices and using school personnel and peers as role models. This will presumably result in healthier weight, better fitness and not least in new familiar healthy habits.

NCT ID: NCT01170377 Completed - Mental Retardation Clinical Trials

Effect of Valproate on Propofol

Start date: April 2007
Phase: N/A
Study type: Observational

The aim of this study is to evaluate the effect of valproate on the required dose of propofol for sedation in patients with mental retardation.

NCT ID: NCT01151462 Withdrawn - Hearing Loss Clinical Trials

Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.

Start date: August 2010
Phase:
Study type: Observational

The aim of this study is to investigate short and long term consequences from early postnatal HCMV infection transmitted via human milk in very preterm infants (birth weight < 1500 g or gestational age < 32 weeks). These infants are at high risk of early death or survival with chronic disease and neurodevelopmental impairment if infected with HCMV. Infection is a common complication in this group of patients and reported to be the most frequent cause of death after the second week of life. Systemic infection in the newborn period is reported as representing an independent risk factor for survival with neurodevelopmental impairment among very preterm infants.

NCT ID: NCT01043822 Recruiting - Autism Clinical Trials

Pain and Emotional Expression in Children With Autism or Mental Retardation

Start date: December 2009
Phase: N/A
Study type: Observational

The purpose of this study is to describe facial, behavioral and physiologic (heart rate) reactivity of children with autism aged 3 to 6 years old, during a painful stimulation (venepuncture). Children will be videotaped before, during and after a venepuncture. Each recording will be rated with the FACS (Facial Action Coding System) and the NCCPC (Non Communicating Children's Pain Checklist).